Showing results (451-460 of 884) with videos related to

Sort By:
Pageof 89
Gut|November 14, 2013
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisSiddharth Singh, Sushil Kumar Garg, Preet Paul Singh, et al.
United European Gastroenterology Journal|May 13, 2022
Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysisAilsa Hart, Geert D'Haens, Mareike Bereswill, et al.
Inflammatory Bowel Diseases|January 16, 2023
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study ResultsJulian Panés, Edward V Loftus, Peter D R Higgins, et al.
Gastroenterology|November 5, 2003
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States communityKiran Bambha, W Ray Kim, Jayant Talwalkar, et al.
Inflammatory Bowel Diseases|June 16, 2011
Primary intestinal lymphoma in patients with inflammatory bowel disease: a descriptive series from the prebiologic therapy eraStefan D Holubar, Eric J Dozois, Edward V Loftus, et al.
Dermatology (Basel, Switzerland)|July 27, 2025
Magnetic Resonance Imaging for Distinguishing Perianal Hidradenitis Suppurativa from Fistulizing Crohn DiseaseMika Yamanaka-Takaichi, Edward V Loftus, David Anthony Wetter, et al.
The American Journal of Gastroenterology|May 7, 2004
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapyJean Frédéric Colombel, Edward V Loftus, William J Tremaine, et al.
Inflammatory Bowel Diseases|November 7, 2022
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical ProgramGary R Lichtenstein, Brian Bressler, Carlos Francisconi, et al.
Inflammatory Bowel Diseases|February 22, 2023
The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel DiseaseSiri A Urquhart, Bryce P Comstock, Mauricio F Jin, et al.
Advances in Therapy|March 14, 2023
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's DiseaseEdward V Loftus, Jenny Griffith, Ezequiel Neimark, et al.
Pageof 89